BGNE
BeiGene, Ltd.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
John V. Oyler
IPO Date
2016-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BeiGene, Ltd.
CEO
John V. Oyler
IPO Date
2016-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 22,750 |
| $18.19 |
| 22 May 2025 | Sharp Shalini | director | A-Award | Acquired | 10,985 | $0.00 |
| 22 May 2025 | Sharp Shalini | director | A-Award | Acquired | 22,750 | $18.19 |
| 22 May 2025 | BRANDICOURT OLIVIER | director | A-Award | Acquired | 10,985 | $0.00 |
| 22 May 2025 | BRANDICOURT OLIVIER | director | A-Award | Acquired | 22,750 | $18.19 |
| 22 May 2025 | Riva Alessandro | director | A-Award | Acquired | 10,985 | $0.00 |
| 22 May 2025 | Riva Alessandro | director | A-Award | Acquired | 22,750 | $18.19 |
| 22 May 2025 | Dugan Margaret | director | A-Award | Acquired | 10,985 | $0.00 |
| 22 May 2025 | Dugan Margaret | director | A-Award | Acquired | 22,750 | $18.19 |
| $1,001 - $15,000 |